Originator Organization |
Active Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 1 | GB | - | |
Neoplasms | Preclinical | NL | - | |
Neoplasms | Discovery | US | - |